Pulmonary Hypertension in Pregnancy: Challenges and Solutions
Hesham Afify,Alexander Kong,Jopher Bernal,Islam Y Elgendy
DOI: https://doi.org/10.2147/IBPC.S242242
2022-04-02
Integrated Blood Pressure Control
Abstract:Hesham Afify, 1, 2 Alexander Kong, 1, 2 Jopher Bernal, 1, 2 Islam Y Elgendy 3 1 Department of Internal Medicine, University of Central Florida HCA Healthcare GME, Greater Orlando, FL, USA; 2 Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, USA; 3 Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY, USA Correspondence: Islam Y Elgendy, Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, KY, USA, Email Pulmonary hypertension (PH) is a heterogeneous disease characterized by an elevated mean pulmonary artery pressure of 20 mm Hg or above. PH is a prevalent condition among women of reproductive age and is linked with poor prognosis during pregnancy. Pregnancy is a stressful event and complicates the management and prognosis in patients with PH. In this review, we discuss the pathogenesis, clinical presentation as well as therapeutic options for PH during pregnancy. We also highlight knowledge gaps to guide future research. Keywords: pulmonary hypertension, pulmonary arterial hypertension, pregnancy, women Cardiovascular diseases are one of the leading causes of preventable maternal morbidity and mortality in developed countries, including the United States (US). 1 Pulmonary hypertension (PH) among pregnant women carries a high mortality risk for both the mother and fetus, with some data suggesting that the maternal mortality rate is as high as 30–56%. 2 In recent years, studies have shown a decline in maternal mortality among pregnant women with well controlled PH, with mortality rates ranging from 9–25%. 3–5 Primary pulmonary arterial hypertension (PAH) is the most prevalent type of PH among women of reproductive age, and it is 2–4 times more common among women compared with men, 6,7 with a median survival rate of 2.8 years among untreated non-pregnant women. 8,9 Societal guidelines recommend against pregnancy in patients with PH because of the high maternal mortality. 10,11 Despite these recommendations, a number of women with PH decide to become pregnant while others might be diagnosed with PH for the first-time during pregnancy. In one study, 1 out of 4 women with PH associated with congenital heart disease (CHD) and 16% of primary PAH were diagnosed for the first time during pregnancy. 12 In this review, we provide an overview for the pathogenesis, clinical presentation as well as therapeutic options for PH during pregnancy. PH is a heterogenous disease that could be primary or secondary to other conditions. It is defined as a mean pulmonary arterial pressure (mPAP) ≥20 mmHg at rest. 13,14 However, using a threshold value for PAP alone might not be sufficient to characterize PH. To better define PH, the values of both pulmonary capillary wedge pressure (PCWP) and pulmonary vascular resistance (PVR) are helpful, thus right heart catheterization (RHC) is usually indicated to confirm the diagnosis, especially among non-pregnant women. The 6th World Symposium on PH proposed a cut off value for PVR ≥3 Wood Units (WU) and PCWP >15 mmHg to further classify PH. 13 Accordingly, PH is classified hemodynamically into pre-capillary, post-capillary, and combined pre- and post-capillary PH. Clinically, PH is classified into 5 main groups: i) group 1: PAH; ii) group 2: PH secondary to left-sided heart disease; iii) group 3: PH secondary to lung disease and hypoxia; iv) group 4: PH due to PA obstruction; and v) group 5: PH with unclear mechanism. 13 As such, pre-capillary PH would be characterized by mPAP ≥20 mmHg, PCWP ≤15 mmHg and PVR ≥3 WU corresponding clinically with groups 1, 3 and 4. Group 2 PH secondary to left-sided heart disease is distinguished by high PCWP >15mmHg together with elevated mPAP >20 mmHg. Depending on PVR, it can be further subclassified as isolated post-capillary PH or mixed pre- and post-capillary PH. Isolated post-capillary PH with PVR <3 WU and combined pre- and post-capillary PH with PVR ≥3 WU. Group 5 PH is a miscellaneous group of diseases with unclear multifactorial mechanisms that leads to PH which can manifest with either hemodynamic change (Table 1). Table 1 Clinical and hemodynamic classification of pulmonary hypertension (PH) using the World Health Organization's 6th Symposium classification system The most common causes of PH during pregnancy are PH associated with CHD and PAH (ie, group 1). In a systematic review of 13 studies with 272 pregnancies with PH between 2008 and 2018, the common underlying etiologies were PH associated with CHD (64%), of which 30% had Eisenmenger syndrome, followed by PAH (22%). 15 -Abstract Truncated-
English Else